Holmes votes in favor of SB3049 to broaden and rename newborn screening committee

During the 104th General Assembly on May 31, 2026, Sen. Linda Holmes (D-42nd) cast a Yes vote on SB3049, which aims to rename and expand the newborn screening advisory committee. The Illinois Senate approved the legislation with a 54-0 margin.

As outlined in the bill's official language, the legislation concerns "NEWBORN METABOLIC SCREENING."

The summary below provides an analysis of the bill text and may interpret its key provisions for clarification.

This legislation changes the name of the Genetic and Metabolic Diseases Advisory Committee to the Universal Newborn Screening Advisory Committee and expands its responsibilities regarding Illinois’ newborn screening program. The revised committee is required to convene every quarter beginning July 1, 2026, conduct periodic reviews of medical conditions that qualify under federal or treatment-based measures, and specifically consider several rare conditions—such as certain mucopolysaccharidoses and Batten disease type 2—for inclusion in the newborn screening list. Additionally, the measure establishes deadlines for assessments, state determinations, lab execution, and annual reporting to the public, while also updating related laws, including the Rare Disease Commission Act. The bill becomes effective immediately.

The recorded action for SB3049 was 'House Committee Amendment No. 1 Senate Concurs'.

Holmes earned a BA from National College of Education in 1984.

The Illinois State Senate's 42nd District has been represented by Holmes, a Democrat, since her election in 2007, succeeding the former senator Phyllis Petka.

Legislation in Illinois goes through a multi-step process that starts with introduction in either legislative chamber, followed by committee evaluations, floor debates, and approval votes before a bill can be sent to the governor for signing or veto. In each biennial session, thousands of measures are introduced, but only a select few advance to become law.